Rheuma s.r.o.

The trials here

What the 7 trials at this site are about, from their registry records.

Conditions

• Psoriatic arthritis6 trials
• Psoriasis4 trials
• Rheumatoid arthritis1 trial

Phase

• Phase 35 trials
• Phase 21 trial

Status

• Active, not recruiting3 trials
• Completed2 trials
• Not yet recruiting1 trial
• Suspended1 trial

Lead sponsor

• Janssen Research & Development, LLC4 trials
• MoonLake Immunotherapeutics AG2 trials
• Pfizer1 trial

Running trials

• Not yet recruiting

  A study to evaluate the long-term safety, tolerability, and efficacy of subcutaneous sonelokimab in participants with psoriatic arthritis (PsA)

  2025-522471-28-00· Phase 3· MoonLake Immunotherapeutics AG· Source

• Active, not recruiting

  A study to investigate the efficacy and safety of subcutaneous sonelokimab versus placebo in participants aged 18 years and over with active psoriatic arthritis who are naive to biologic DMARDs

  2024-516213-20-00· Phase 3· MoonLake Immunotherapeutics AG· Source

• Active, not recruiting

  A Study to Evaluate the Efficacy and Safety of JNJ-77242113 (Icotrokinra) in Biologic-naïve Participants With Active Psoriatic Arthritis

  NCT06878404· Phase 3· Janssen Research & Development, LLC· Source

• Active, not recruiting

  A Study to Evaluate the Efficacy and Safety of Icotrokinra (JNJ-77242113) in Biologic-experienced and Biologic-naive Participants With Active Psoriatic Arthritis

  NCT06807424· Phase 3· Janssen Research & Development, LLC· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Psoriatic arthritis1 recruiting

Closed trials

• Completed

  Guselkumab in Active Psoriatic Arthritis Participants With Inadequate Response/Intolerance to One Prior Anti-TNF Alpha Agent

  NCT04936308· Phase 3· Janssen Research & Development, LLC· Source

• Completed

  Changes of Depression After First-year of Tofacitinib in RA Patients

  NCT03992781· Pfizer· Source